These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 2175539)

  • 41. Platelet 3H-imipramine and 3H-paroxetine binding during treatment with psychoactive drugs.
    Mellerup ET; Dam H; Lauritzen L; Plenge P
    Biol Psychiatry; 1991 Nov; 30(10):1056-8. PubMed ID: 1836743
    [No Abstract]   [Full Text] [Related]  

  • 42. Imipramine binding sites on platelets of patients with major depressive disorder.
    Carstens ME; Engelbrecht AH; Russell VA; Aalbers C; Gagiano CA; Chalton DO; Taljaard JJ
    Psychiatry Res; 1986 Aug; 18(4):333-42. PubMed ID: 3018818
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 3H-imipramine binding in platelets: influence of varying proportions of intact platelets in membrane preparations on binding.
    Friedl W; Propping P; Weck B
    Psychopharmacology (Berl); 1983; 80(1):96-9. PubMed ID: 6306712
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition and dissociation of [3H]-paroxetine binding to human platelets.
    Andersson A; Marcusson J
    Neuropsychobiology; 1989; 22(3):135-40. PubMed ID: 2535005
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Circannual variations in the density of tritiated imipramine binding sites on blood platelets in man.
    Egrise D; Desmedt D; Schoutens A; Mendlewicz J
    Neuropsychobiology; 1983; 10(2-3):101-2. PubMed ID: 6325993
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Platelet [3H]-imipramine binding according to DSM-III subtypes of depression.
    Jeanningros R; Gronier B; Azorin JM; Tissot R
    Neuropsychobiology; 1989; 22(1):33-40. PubMed ID: 2561683
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Platelet [3H]imipramine and [3H]paroxetine binding in depressed patients.
    Rosel P; Menchón JM; Vallejo J; Arranz B; Navarro MA; Lirón F; Alvarez P
    J Affect Disord; 1997 Jun; 44(1):79-85. PubMed ID: 9186805
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Platelet serotonin uptake and 3H-imipramine binding in panic disorder.
    Norman TR; Sartor DM; Judd FK; Burrows GD; Gregory MS; McIntyre IM
    J Affect Disord; 1989; 17(1):77-81. PubMed ID: 2544638
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of protein concentration on kinetic constants (Kd and Bmax) of 3H-imipramine binding in blood platelets.
    Arora RC; Wunnicke V; Meltzer HY
    Biol Psychiatry; 1985 Jan; 20(1):116-9. PubMed ID: 2981127
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Platelet [3H]imipramine binding in depressed patients and its circadian variations in healthy controls.
    Nankai M; Yoshimoto S; Narita K; Takahashi R
    J Affect Disord; 1986; 11(3):207-12. PubMed ID: 3031144
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Altered platelet 3H-imipramine binding in schizo-affective and depressive disorders.
    Suranyi-Cadotte BE; Wood PL; Schwartz G; Nair NP
    Biol Psychiatry; 1983 Aug; 18(8):923-7. PubMed ID: 6311293
    [No Abstract]   [Full Text] [Related]  

  • 52. Platelet tritiated imipramine binding in psychiatric patients: relationship to symptoms and severity of depression.
    Ellis PM; McIntosh CJ; Beeston R; Salmond CE; Cooke RR; Mellsop G
    Acta Psychiatr Scand; 1990 Oct; 82(4):275-82. PubMed ID: 2175538
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Binding of [3H]imipramine to human platelet membranes with compensation for saturable binding to filters and its implication for binding studies with brain membranes.
    Phillips OM; Wood KM; Williams DC
    J Neurochem; 1984 Aug; 43(2):479-86. PubMed ID: 6330301
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sleep deprivation and imipramine binding sites in depressed patients and healthy subjects.
    Haug HJ; Fähndrich E; Strauss S; Rommelspacher H
    Psychiatry Res; 1988 Aug; 25(2):135-44. PubMed ID: 2845457
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anti-imipramine antibodies recognize endogenous serotonin uptake and imipramine binding inhibitors.
    Tang SW; Cheung S; Strijewski A; Chudzik J; Helmeste D
    Psychiatry Res; 1990 Nov; 34(2):205-12. PubMed ID: 1962863
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Platelet 3H-imipramine binding and red blood cell choline in affective disorders: indications of heterogeneous pathogenesis.
    Wood PL; Suranyi-Cadotte B; Schwartz G; Nair NP
    Biol Psychiatry; 1983 Jun; 18(6):715-9. PubMed ID: 6307404
    [No Abstract]   [Full Text] [Related]  

  • 57. Platelet imipramine binding in intensive care unit suicidal patients.
    De Leo D; Caneva A; Marazziti D; Conti L
    Eur Arch Psychiatry Clin Neurosci; 1991; 241(2):85-7. PubMed ID: 1657200
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical and treatment effects on 3H-clonidine and 3H-imipramine binding in elderly depressed patients.
    Georgotas A; Schweitzer J; McCue RE; Armour M; Friedhoff AJ
    Life Sci; 1987 Jun; 40(22):2137-43. PubMed ID: 3035303
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of fluoxetine treatment of platelet 3H-imipramine binding, 5-HT uptake and 5-HT content in major depressive disorder.
    Wgner A; Montero D; Mårtensson B; Siwers B; Asberg M
    J Affect Disord; 1990 Oct; 20(2):101-13. PubMed ID: 2176228
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Unaltered platelet [3H]-imipramine binding in dementia of the Alzheimer type.
    Weizman R; Dick J; Mosek A; Tyano S; Rehavi M
    Neuropsychobiology; 1988; 19(2):69-72. PubMed ID: 2852311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.